Disease-specific assessment of quality of life after decompression surgery for Graves' ophthalmopathy

European Journal of Ophthalmology

Volumn 14, Issue 3, 2004, Pages 193-199

  Tehrani, Mana ^a,b   Krummenauer, F ^a   Mann, W J ^a   Pitz, S ^a   Dick, H B ^a   Kahaly, G J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Ophthalmopathy; Orbital decompression; Quality of life; Thyroid associated

Indexed keywords

ACID GLYCOSAMINOGLYCAN;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; DECOMPRESSION SURGERY; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE COMPRESSION; OPTIC NERVE DISEASE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL BEHAVIOR; STATISTICAL ANALYSIS; GRAVES DISEASE; MIDDLE AGED; ORBIT; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PSYCHOLOGICAL ASPECT;

ADULT; AGED; DECOMPRESSION, SURGICAL; FEMALE; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; ORBIT; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; POSTOPERATIVE PERIOD; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 3142596500     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210401400302     Document Type: Article

References (26)

1. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-9.
2. Wenzel M, Altgassen G. Satisfaction of cataract patients. Klin Monatsbl Augenheilkd 1996; 209: 215-9.
3. Study protocol for the World Health Organisation project to develop a quality of life assessment instrument (WHOQOL). Qual Life Res 1993; 2: 153-9.
4. Pappa A, Lawson JM, Calder V, Fells P, Lightman S. T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy. Br J Ophthalmol 2000; 84: 517-22.
5. Kazim M, Goldberg RA, Smith TJ. Insights into the pathogenesis of thyroid -associated orbitopathy: evolving rationale for therapy. Arch Ophthalmol 2002; 120: 380-6.
6. Kahaly G, Forster G, Hansen C. Glycosaminoglycans in thyroid eye disease. Thyroid 1998; 8: 429-32.
7. Khwarg SI, Lemke BN. Thyroid eye disease. Arch Ophthalmol 1999; 117: 143.
8. Keltner JL. Is Graves' ophthalmopathy a preventable disease? Arch Ophthalmol 1998; 116: 1106-7.
9. Haddad HM, Keltner JL. Graves' ophthalmopathy. Arch Ophthalmol 1999; 117: 700.
10. Warwar RE. New insights into pathogenesis and potential therapeutic options for Graves' orbitopathy. Curr Opin Ophthalmol 1999; 10: 358-61.
11. Goldberg RA. The evolving paradigm of orbital decompression surgery. Arch Ophthalmol 1998; 116: 95-6.
12. Mann W, Kahaly GJ, Pitz S, et al. Decompression surgery for thyroid-associated orbitopathy: a ten year experience. Exp Clin Endocrinol Diabetes 1999; 107 (Suppl): S212-3.
13. Egle UT, Kahaly GJ, Petrak F, et al. The relevance of physical and psychosocial factors for the quality of life in patients with thyroid-associated orbitopathy (GO). Exp Clin Endocrinol Diabetes 1999; 107 (Suppl): S168-71.
14. Kahaly GJ, Hardt J, Petrak F, Egle UT. Psychosocial factors in subjects with thyroid-associated ophthalmopathy. Thyroid 2002; 12: 237-9.
15. Khan JA, Doane JF, Whitacre M. Does decompression diminish the discomfort of severe dysthyroid orbitopathy? Ophthalmic Plast Reconstr Surg 1995; 11: 109-12.
16. Winsa B, Adami HO, Bergstrom R, et al. Stressful life events and Graves' disease. Lancet 1991; 14: 1475-9.
17. Reichlin S. Stressful life events and Graves' disease. Lancet 1993; 13: 1248.
18. Winsa B, Adami HO, Bergstrom R, et al. Stressful life events and Graves' disease. Lancet 1991; 14: 1475-9.
19. Gerding MN, Terwee CB, Dekker FW, et al. Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 1997; 7: 885-9.
20. Terwee CB, Gerding MN, Dekker FW, et al. Test-retest reliability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves' ophthalmopathy. J Clin Epidemiol 1999; 52: 875-84.
21. Terwee CB, Gerding MN, Dekker FW, et al. Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. Br J Ophthalmol 1998; 82: 773-9.
22. Terwee CB, Dekker FW, Mourits MP, et al. Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. Clin Endocrinol 2001; 54: 391-8.
23. Bartley GB, Fatourechi V, Kadrmas EF, et al. Long-term follow-up of Graves' ophthalmopathy in an incidence cohort. Ophthalmology 1996; 103: 958-62.
24. Ware JE, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998; 51: 903-12.
25. Salek S. Compendium of Quality of Life Instruments (vol 2, selection 2G). New York: John Wiley & Sons; 1999: 11-8.
26. Smith KW, Avis NE. Measuring quality of life. Med Princ Prac 1996; 6: 171-6.